Buck Institute in the News
Buck President and CEO Eric Verdin and faculty members Gordon Lithgow and Pankaj Kapahi were quoted in the April 3 issue of The New Yorker, in an article entitled "Silicon Valley's Quest to Live Forever." Verdin and faculty member Judith Campisi were quoted the following week in Town & Country in an article titled "Are you rich enough to live forever?"
Buck faculty Gordon Lithgow talks about the search for healthspan-extending drugs - in experiments that utilize the nematode worm C. elegans. In the podcast he also talks about the role of protein aggregation on the aging process.
Buck faculty Gordon Lithgow and postdoc Katie Dumas explained their work in vitamin D in a story that ran on KGO-TV, the local ABC station, on February 10th.
The Marin Independent Journal covered a study from the Kapahi lab on February 6th. Researchers found that the supplement alpha-lipoic acid prevented a rare kidney disease in mice. A clinical trial is underway at UCSF.
In a study published on January 12, the Lamba lab showed they restored vision in blind mice by transplanting human photorecepters and blocking an immune response tied to transplant rejection. CIRM covered the study in their blog, as did the North Bay Business Journal.
Buck faculty Judith Campisi was extensively quoted in an article appearing in Stat News on January 3. "You may have more control over aging than you think" focused on science related to telomeres.
The Marin Independent Journal covered the appointment of new President and CEO Eric Verdin on November 19th. The story also mentioned a $10 million donation from the Board of Trustees, the largest single, collective donation since the Institute's inception in 1999.
The Marin Independent Journal published a "Marin Voice" column on November 8th. "Buck Institute's future and the science of aging" was co-authored by Buck CEO Edward Lanphier and Board Chair Larry Rosenberger.
Research from the Lithgow lab was featured on the front page of The Press Democrat on November 8th in an article titled, "Buck Institute finds vitamin D may extend lifespan."
Buck CEO Brian Kennedy appeared on the RARECast podcast in early September. He discussed rare genetic diseases that cause children to suffer from advanced aging as children and how that research on those diseases can inform aging research.
The Marin Independent Journal featured a story on research from the Ramanathan lab on August 11th. The piece detailed efforts to develop a treatment for macular degeneration from a compound abundant in broccoli.
Buck faculty Judith Campisi, PhD, was among those interviewed for a story that appeared August 7th in the Toronto Star, "The search for the 'holy grail' of human longevity."
Buck faculty Dr. Arvind Ramanathan was interviewed for the RARECast podcast in early August. He discussed research that shows the diabetes drug metformin could be a treatment for a rare pediatric disease - maple syrup urine disease.
A study from the Jasper and Lamba labs publishing in Science made front page news in the Marin Independent Journal on July 6th. The study focused on a natural protein that may speed the use of stem cell therapies for macular degeneration.
The new solar carport project at the Buck Institute made front page news in the Marin Independent Journal on Friday May 13.
Buck faculty Judith Campisi and Gordon Lithgow were featured on the BBC Radio in their Future Proofing series. The program was all about aging -from research at the Buck to implications for society. The program aired on April 27th.
Buck CEO Brian Kennedy was quoted in The Washington Post on April 18th in a story about the promise of aging research.
Generation Bold Radio interviewed Brian Kennedy for a podcast that posted in February. The program covered Buck science, aging research and how the field matters to individuals and society. Take a listen!
Buck CEO Brian Kennedy participated in a national debate produced by Intelligence Squared on February 3rd. The debate topic was "Lifespans are Long Enough." The debate is posted online. STAT News was among the first to cover the debate.
Buck faculty Judith Campis is a co-founder of Unity Biotechnology, which launched on February 3rd. The story was covered by several outlets, including The San Francisco Business Times.
The Bredesen lab published a study in The Journal of Neuroscience on January 20th which provides a roadmap for a "unified theory" of Alzheimer's disease. The story was covered in The Marin Independent Journal, The Scientist, and the website Genome News.
Buck President and CEO Brian Kennedy was quoted in an article in the Orange County Register that focused on the future of aging.
Buck faculty Chris Benz, MD was quoted in the Oct 1 edition of The Marin Independent Journal, in a story that highlighted new funding for a project involving data from the Marin Women's Study.
Research from the Brand lab was featured in "Stopping Free Radicals at their Source," a story posted on the website of the Genomics Institute of the Novartis Research Foundation. The piece posted on September 23rd.
On September 16 the UCLA Newsroom featured an article based on research by the Buck Institute's Dale Bredesen, MD. The study shows that Alzheimer’s disease consists of three distinct disease variations.
California's new stem cell bank opened at the Buck Institute on September 1. The story was front page news in the Marin Independent Journal.
The August 24 edition of the North Bay Business Journal ran the second story in a series that focuses on research involving Dale's Bredesen's groundbreaking program on Alzheimer's.
The August 17 edition of the North Bay Business Journal ran an extensive front page story on Alzheimer's research at the Buck Institute involving Dale Bredesen.
The August issue of Marin Magazine featured the second of a series of articles on healthy aging - with a particular emphasis on cognitive decline and gut health.
A study from the Campisi lab was featured on the July 7 front page of The Marin Independent Journal. The study focused on the benefits of intermittent dosing with the drug rapamycin.
On July 6, The North Bay Business Journal published the first of a 3-part series focused on Buck Institute science and business partnerships.
The July issue of Marin Magazine featured the first of a series of articles on healthy aging. "The Science of Aging" featured interviews with Buck CEO Brian Kennedy and professor Gordon Lithgow.
On June 15, The Marin Independent Journal published "Buck Institute helps identify genetic link to chronic itch," based on research from the Brem lab that published in Neuron.
Buck faculty Simon Melov was quoted in the May edition of MIT's The Technologist, in an article titled, "How old are you really?"
The Buck Institute signed a partnership agreement with Google-founded Calico on April 28. The story was covered by several media outlets, including The San Francisco Business Times, and The Marin Independent Journal.
The Santa Rosa Press Democrat featured a story on "Feeding your brain: Mind what you eat" on February 18th. The article, which featured an interview with Dale Bredesen, previewed the February 28 "Healthy Mind Cookbook" event.
Buck CEO Brian Kennedy was quoted in February 12 cover story in Businessweek. The story, "Does a real anti-aging pill already exist?" focuses on rapamycin.
Faculty member Judith Campisi was quoted on Today.com on January 15 in a story "How old is your body really?"
Buck CEO Brian Kennedy was quoted in a long piece for The Guardian, a UK publication. The story, "Scientists say we'll live well beyond 120" ran on January 11.
The Kennedy lab published a study on December 18 showing that ibuprofen extends lifespan in yeast, worms and flies. The story got extensive coverage: KABC-TV (ABC Los Angeles) KGO-TV (ABC San Francisco); KTVU-TV (Fox San Francisco) front page in The San Francisco Chronicle, Yahoo Health, The Daily Mail in the UK, USA Today, among others.
The Santa Rosa Press Democrat covered the Buck Institute's first clinical trial in a story that ran on December 1.
Dr. Dale Bredesen was among the guests appearing on KQED's Forum program on November 25th, in a wide-ranging discussion about Alzheimer's disease.
Research from Dr. Dale Bredesen was featured on KGO-TV on November 7. The story "Regimen rolls back symptoms of Alzheimer's disease" focused on his new MEND (Metabolic Enhancement for Neurodegeneration) program.
Buck CEO Brian Kennedy was lead author of a commentary publishing in the November 6 issue of Cell. The commentary, coauthored by a number of othe prominent age researchers, set for a strategy for advancing Geroscience at the National Institutes of Health. Read our news release.
Buck CEO Brian Kennedy and faculty member Gordon Lithgow were quoted in El Mercurio, a major Chilean newspaper, in an October 11 article "What if we live to 100 years?"
Research from Dr.Dale Bredesen was featured on the front page of the Marin Independent Journal on October 1st. The story, "Hopeful research in treating Alzheimer's" focused on a study involving 10 patients and a new system-based approach to treating the disease.
Buck faculty Christopher Benz, MD was featured in both the San Francisco Chronicle and the The Marin Independent Journal regarding a publication on August 7th in Cell. The study - the largest genomic analysis of its kind - suggested a new "disruptive" method for reclassifying cancers.
Buck CEO Brian Kennedy was interviewed for an article appearing in Chile's major national newspaper El Mercurio on August 1. The article was titled, "Science looks for ways to have more years in good health."
On July 31 The Marin Independent Journal highlighted the new Buck spinoff LabCures in a front page story. LabCures is focused on using the internet to raise money for lab-based research.
Two commentaries on aging research were published in the prestigious journal Nature on July 23. One was co-authored by Buck CEO Brian Kennedy, the other by faculty member Simon Melov.
The California Institute for Regenerative Medicine highlights the work of K-12 Education Coordinator Julie Mangada in a blog post on July 9.
Congratulations to former Buck Summer Scholar (and stem cell scientist) Lauren Killingsworth! The Stanford-bound student wins $80,000 scholarship from PG & E and gets a big splash in The Marin Independent Journal.
Ultramarathon runner and Buck postdoctoral fellow Matthew Laye was featured in a "Marin Snapshot" in the March 23 edition of The Marin Independent Journal.
Long-time Buck Institute Board of Trustee Catherine Munson died on March 3, following a brief illness. In its obituary The Marin Independent Journal detailed her civic involvement and career success.
The Daily Mail was among the international papers that covered a January 16 study from the Jasper lab that suggests having healthy gut bacteria could be the key to living a long, healthy life.
NIH Director Frances Collins blog highlighted research from the Kapahi lab, focusing on healthspan-extending possibilities from a study that involved crossing mutations in nematodes. The blog posted January 7.
The Kapahi lab published a study in Cell Reports showing the crossing mutations in nematodes resulted in a five-fold synergistic lifespan expansion. The story was covered in many publications including the Marin Independent Journal and the Los Angeles Times.
Buck professor Gordon Lithgow, PhD, was featured in an article in the Chronicle of Higher Education posting December 9. The story focuses on efforts at the NIH to develop treatments to slow the aging process.
Buck faculty Dale Bredesen, MD, was quoted in the lead story in the San Francisco Chronicle's Health Section on November 20. The story, "Alzheimer's Disease: New ideas in search for a cure" summarized research at several Bay area institutions.
The Bredesen lab published a study in The Proceedings of the National Academy of Science focused on the connection between a genetic risk factor for Alzheimer's and a well-known "anti-aging" protein. The study was covered on the front page of The Marin Independent Journal, The Santa Rosa Press Democrat and on the Fox News Health Site.
The Santa Rosa Press Democrat ran a guest opinion piece on Sunday June 30, "Science Struggles for Funding." The piece featured the work of faculty Simon Melov and other research underway at the Buck Institute.
The Marin Independent Journal ran a front page story on June 11 covering a study from the Melov lab focusing on rapamycin and a study that showed the drug reversed heart disease in elderly mice.
On May 1st, Buck Institute President and CEO Brian Kennedy appeared on "Chicago Tonight" on WTTW-TV, the leading PBS station in Chicago.
The Santa Rosa Press Democrat did a story about the first grade school class to visit the Buck Institute's new Learning Center. The story, replete with many photos, ran on April 18. The Marin Independent Journal attended the April 20 Grand Opening of the Center. Their story spread also included a video with one of the young scientists volunteering at the event.
The Marin Independent Journal ran a front page story, "Accelerator of Research; Stem cell bank to be based at Buck Institute" on March 29.
|On March 7, Buck faculty Dale Bredesen, MD, and Pankaj Kapahi, PhD, appeared on KQED's Forum program to discuss "How to Eat For a Longer Life." Hosted by Michael Krasny, the program is among the most popular at KQED, the most-listened-to NPR station in the country.|
On March 7, the Marin Independent Journal ran a front page story on local impact of the federal budget sequestration. "Federal budget cuts hit county; Buck Institute, Hospice by the Bay feel squeeze of sequestration."
The Chilean newspaper La Tercera ran a major article on January 26 "Aging will be the most important medical problem within the next 10 or 15 years," featuring an interview with Buck CEO Brian Kennedy. The issue also included a column by Kennedy and Senior Vice-President for External Affairs, Raja Kamal titled, "A national healthy aging campaign: the basics."
Buck faculty Lisa Ellerby, PhD, appeared in the January 15 edition of The Scientists in an article "Bespoke stem cells for brain disease." Ellerby's lab is focused on developing treatments for Huntington's disease.
The Marin Independent Journal ran a "Marin Voice" op-ed by Buck faculty Dale Bredesen, MD on Sunday January 7. The piece was titled "The Healthiest Town in America."
Buck faculty Brad Gibson, PhD, was interviewed for an article appearing in the January edition of Nature Methods: "Method of the Year - Targeted Proteomics."
Faculty member Judith Campisi, PhD, was quoted in a December article in a special supplement of Nature, focusing on aging and the promise of stem cell therapy. The entire issue covered aging research and issues related to an aging population.
Scientists at the Buck Institute have identified hundreds of "druggable" molecular targets for Huntington's disease. The genome-wide screening featured the use of RNAi technology and was published in PLoS Genetics. The research was covered in many biotechnology publications as well as the Marin Independent Journal.
Buck Institute Trustee Art Gensler and his wife Drue have donated $5 million to the Institute. The Marin Independent Journal ran a front page story about the gift on November 3rd. The San Francisco Business Times covered the story in their online edition, as well as the North Bay Business Journal.
The Santa Rosa Press Democrat covered the October 27th North Bay Discovery Day event. At least 7,000 people attended the Bay Area Science Festival signature event, which was held at the Sonoma County Fairgrounds in Santa Rosa.
Nature published a landmark breast cancer study on September 23rd, following unprecedented genetic analysis of tumors from 825 patients. The Benz lab, in partnership with UC Santa Cruz, made significant contributions to the study. The San Francisco Chronicle ran a front page story on September 24th, as did the Marin Independent Journal.
On September 17, CEO Brian Kennedy was quoted in an article about the effects of rapamycin on longevity in the Boston Globe.
The Fall 2012 edition of Marin Medicine included an article by faculty member Deepak Lamba, MBBS, PhD, on "Stem Cell Therapeutics for Retinal Degenerations."
Buck faculty Deepak Lamba was awarded $1.5 million from the California Institute for Regenerative Medicine on September 6 to build a 3-D model of the retina. The Marin Independent Journal covered the grant, which is aimed at understanding retinitis pigmentosa.
Buck faculty Judith Campisi did a video interview for Scientific American which posted August 8th. Campisi discusses the "cons of chemotherapy", explaining that some treatments cause cellular senesence, which stop cell growth but also cause inflammation in surrounding tissues. This inflammation can pose a risk factor for cancer.
KTSF, the San Francisco based Chinese language television station, aired a story about Buck faculty Xianmin Zeng, PhD, and her work involving stem cell technology and Parkinson's disease.
Buck Institute CEO Brian Kennedy, PhD, was interviewed for a Burrill Report podcast that posted on July 13. The report focused on regenerative medicine and aging research, and in particular on studies involving the drug rapamycin.
The Kapahi lab published a study on July 3 in Cell Metabolism. They determined that fruit flies on dietary restriction (DR) need to be physically active in order to get the lifespan extending benefits that come from their Spartan diet. If the same axiom holds true in humans, those practicing caloric restriction in hopes of living longer need to make sure they eat enough to avoid fatigue. The study was featured in the Marin Independent Journal.
Scientists from the Ellerby lab report that they have corrected the genetic mutation responsible for Huntington's disease in induced pluripotent stem cells. The research, featured in Cell Stem Cell published on June 28. The study was featured in the San Francisco Business Times.
The Greenberg lab published a study on May 22 in the prestigious journal The Proceedings of the National Academy of Sciences. The research, which was covered in a front page story in the Marin Independent Journal focused on modifying scar tissue as a potential therapeutic target for the treatment of chronic stroke.
The Marin Independent Journal previewed the opening of the new Regenerative Medicine Research Center on Friday April 13. One story focused on construction (and the fact that it came in under budget). The other included a history of the project. The San Francisco Business Times used the formal opening of the building to do a story about stem cell research.
The North Bay Business Journalpublished a special insert on March 26th - celebrating the upcoming opening of the Institute's new Regenerative Medicine Research Center, the third of five buildings approved in the Buck master plan.
The Louisville, KY Courier Journal covered the 100th birthday of Leda Beierle, the grandmother of Buck Institute CEO Brian K. Kennedy, PhD. The article was published March 22. On April 6, USA Today ran another version of the story.
Buck CEO Brian Kennedy was quoted in an article appearing in The Economic Times on February 20. The article talked about the aging population and techological advances that are allowing them to remain independent.
Buck faculty Simon Melov published an article in Science Translational Medicine on February 1 showing that massage reduces inflammation following strenous exercise. The study was featured in many publications, including USA Today, NPR, Huffington Post, and the Marin Independent Journal.
KGO-TV, the San Francisco ABC affiliate, featured a story on the Buck Institute's geothermal project on January 10. The story featured interviews with Ralph O'Rear, VP of Facilities and Nancy Derr, Buck CFO.
Faculty members Judith Campisi and Simon Melov were interviewed by the National Journal for a December 15 article, "Longevity: A Manual."
|Buck faculty Judith Campisi was interviewed for the Dec 4 broadcast of "The Sunday Edition" - a production of the CBC, Canadian Public Broadcasting. The opening segment of the program featured a story on a 92-year old athlete and the implications for age research.|
The Oregonian ran an editorial "Living well for a long time" on November 6, quoting Buck faculty Judith Campisi.
The Santa Rosa Press Democrat ran a op-ed by Buck CEO Brian Kennedy on November 4, calling for more preventative measures for type 2 diabetes.
Buck faculty Judith Campisi was quoted in The New York Times on November 3rd, in a story that covered research involving mice that had been cleared of senescent cells.
Buck faculty Julie Andersen, PhD, was interviewed by KRCB-FM for a story about stem cell research - as a preview for the October 29th "Combating the Challenges of Aging Through Stem Cells" event at Sonoma State University.
The Santa Rosa Press Democrat ran a major feature story on Sunday October 23, based on the September Community Seminar which focused on aging skin. The story featured an interview with Buck faculty, Judith Campisi, PhD.
The Marin Independent Journal ran a front page story on October 15, covering research in the Lunyak lab which has discovered a way to reverse aging in human stem cells.
The Arab Times featured an Op-Ed by Buck CEO Brian Kennedy PhD, on October 7. The article focused on the epidemic of Type II diabetes now impacting the middle East. A similar article appeared in the Kuwait Times.
The International Business Times covered a study from the Lunyak lab on September 24. The research - appearing in Cell Cycle - shows that it is possible to reverse the aging process in human adult stem cells, which helps regenerate old or damaged tissues.
Buck President and CEO Brian K. Kennedy, PhD, was quoted in the Boston Globe and in The Scientist on September 21st -- in stories that dealt with controversies over the role of Sirtuins in lifespan extension and age research.
Buck faculty Christopher Benz, MD was featured in the University of California, San Francisco's Summer newsletter - in an article that covered his role in encouraging the career of Nobel prizewinner Elizabeth Blackburn.
Buck faculty Gordon Lithgow was interviewed in the September issue of the Nob Hill Gazette.
The September issue of Marin Magazine included a story about the growth of the Buck Institute and construction of our new regenerative medicine research building. The Institute was also the site of the fall fashion shoot.
The Marin Independent Journal ran a front page story on August 29th updating activity of the Marin Women's Study. The Buck Institute is a partner in the unique DNA/lifestyle survey involving breast cancer.
The Marin Independent Journal covered the Buck's Summer Scholar Program in story that ran on August 6th.
On Sunday July 24, the Marin Independent Journal ran a front page story about a collaboration between the Buck and UK's Proteome Sciences aimed at developing test to improve breast cancer therapy.
The Buck Institute was named as one of "Marin's Hot 101's" in the August issue of Marin Magazine.
The Novato Patch highlighted the Buck participation in science education in a July 22 story, "Public-Private partners spark interest in math, science among Novato kids."
The Providence Journal ran an Op-Ed authored by Buck faculty Julie Anderson on July 9th: "Are we giving U.S. infants too much iron?"
Both Buck Institute CEO Brian Kennedy, PhD and faculty Christopher Benz, MD took part in a TedX conference in Madagascar. The conference, sponsored by the Akbaraly Foundation focused on women's health in the African nation.
Buck faculty Julie Andersen, PhD, published a paper in the Journal of Neuroscience Research on June 25, focusing on lithium as a potential treatment for Parkinson's disease. The story in the Marin Independent Journal featured an interview with Andersen and comments by the CEO of the Parkinson's Institute. The story was covered on several health-related websites, it was also covered in the UK in The Daily Telegraph.
Faculty Gordon Lithgow, PhD, was interviewed about his work (and his recent paper in Nature) On June 17th in an episode of Futures in Biotech, a podcast hosted by Marc Pelletieir. The program was co-hosted by Buck faculty Simon Melov, PhD.
Buck Institute President and CEO Brian Kennedy talks about the demographics of aging and efforts to increase healthspan on South-South News. South-South News broadcasts news stories and shares best practices on progress toward the United Nations Millenium Development Goals.
The June issue of Outside Magazine included a story Go the Distance; the piece focused on the value of endurance running and featured an interview with faculty Simon Melov.
Buck research focusing on molecular pathways involved in dietary restriction and lifespan extension appears in the May 12 edition of Nature. ABC Science covers the story online along with the Marin Independent Journal.
|Buck faculty member Dale Bredesen, MD and venture philanthropist Douglas Rosenberg appeared on KQED's Forum with Michael Krasny on April 5. The program is the most popular NPR talk show on the West Coast.|
The Lithgow lab published a study in the prestigious journal Nature on March 30th. The research was covered in several venues. KGO-TV, the ABC affiliate in San Francisco did the story as did The New York Times. The story appeared on the front page of the Marin Independent Journal and The Santa Rosa Press Democrat.The story was also covered in New Scientist and Science News.
|Nature's Kerri Smith interviewed Buck faculty Gordon Lithgow for a podcast that was posted on the day of publication.|
The Marin Independent Journal covers March 26 Community Seminar "Stress Less" with Gordon Lithgow and Thea Singer.
Buck Institute President and CEO Brian Kennedy, was the featured Executive Profile in the March 11 issue of the San Francisco Business Times.
Alzheimer's disease research from the Bredesen lab was the focus of a stories that ran on March 7th on KGO-TV, the San Francisco ABC affiliate and on February 25th on KPIX-TV, the San Francisco CBS. Both stories featured interviews with Dr. Dale Bredesen as well as Douglas Rosenberg, who donated $3.5 million to fund drug development in the Bredesen lab.
On February 28, the Institute announced a partnership with philanthropist Douglas Rosenberg, who donated $3.5 million (and pledged to raise $10 million) to the Bredesen laboratory to develop potential treatments for Alzheimer's disease. The story was covered in the San Francisco Business Times, The Santa Rosa Press Democrat, and the Marin Independent Journal.
On February 7, the Marin Independent Journal applauded the effort in an editorial.
January 24, The Santa Rosa Press Democrat highlights the work of our science education coordinator Julie Mangada in an article, "Buck Institute scientist's youthful spirit."
January 21, the Sacramento Bee publishes an Op-Ed written by Buck President and CEO, Brian Kennedy, PhD, "Fountain of youth may be elusive, but let's find the fountain of health."
Buck faculty Judith Campisi, PhD is featured on a podcast from Futures in Biotech, which aired on January 15. The program, co-hosted by faculty member Simon Melov, PhD, focused on the connection between aging and cancer
|January 11, Buck faculty Dr. Dale Bredesen is interviewed on KSRO-AM radio. He discusses Alzheimer's disease and specific research now underway in his laboratory.|
January 10, The Santa Rosa Press Democrat runs a front page story, "North Bay researchers hope for breakthrough on Alzheimer's". The story features an interview with faculty member Dale Bredesen, MD and a photograph from the Bredesen lab.
December 23: "Better Prepare for the Silver Tsunami" an Op-Ed written by Buck President and CEO, Brian Kennedy is published in the Providence Journal.
December 17: Buck President and CEO, Brian Kennedy and faculty member Simon Melov are interviewed for Futures in Biotech, a feature appearing on TWIT TV.
November 21: Buck faculty Simon Melov is quoted in a story about exercise and aging appearing in USA Today.
November 18: Buck faculty Pankaj Kapahi appears in a story on KGO-TV that focuses on the drug rapamycin and alcoholism. Kapahi addressed the use of rapamycin in age research.
October 21: The California Institute for Regenerative Medicine awards $6 million to faculty member Xianmin Zeng to get a stem cell based treatment for Parkinson's disease ready for clinical trial. Read about it in the Marin Independent Journal and the San Francisco Business Times.
The Buck Institute "cements" the future of our new Regenerative Medicine Research building when we pour concrete for the foundation. Read about it in the Marin Independent Journal.
The Marin Independent Journal ran an editorial, “Buck’s deal with BioMarin Shows Great Promise.” August 23
Study from Zeng lab shows treatment with human induced pluripotent stem cells cures Parkinson's disease in rodents. Read the story that ran on August 16
Dr. Dale Bredesen appeared on KPFA-FM’s “Morning Show” hosted by Philip Maldari. The hour-long segment was devoted to an update on Alzheimer’s research and news for consumers. August 15
|KPFA-FM's "Morning Show"|
The Marin Independent Journal covers a study from the Ellerby lab appearing in Neuron --
“Buck finds therapy target for dementia precursor; Huntington study appears in Neuron. July 30
The Marin Independent Journal covers the special public seminar by
Dr. John Rowe -- “Expert: Nation Not Ready to Handle Aging Population”. June 15
The Marin Independent Journal ran a front page story on June 3,: “Buck pushes ahead with stem cell center; without $15 million in stimulus cash, institute to issue bonds for new $41 million facility.” June 3
The Why Files posted a story on a study out of the Kapahi lab: “Big losers take note: It’s all in the biochemistry" May 13
Buck Faculty Dale Bredesen, MD, writes about Alzheimer's research in Marin Medicine. May
North Bay Bohemian cover story highlights Buck Institute stem cell program. April 14
The Marin Independent Journal covers a study from the Greenberg lab, “Buck Institute study offers hope for future treatment for stroke.” April 13
February 28: The Santa Rosa Press Democrat ran a story, “What experts in aging do to age healthfully.”
KGO-TV interviews faculty member Pankaj Kapahi, PhD for “Researchers look at compound to slow effects of aging” November 24
The Marin Independent Journal covers EUREKA grant awarded to Dr. Dale Bredesen. July 7
London's The Telegraph covers Dr. Simon Melov's latest study, "Scientists find way to calculate people's real age." November 19
Dr. Judith Campisi's aging literature review is featured in The Telegraph,"Secrets of immortality could be tantalisingly close." August 27
Canada's Globe and Mail covers Dr. Simon Melov's muscle mass and aging study. May 23